Lifco Ab header image

Lifco Ab

LIFCO B

Equity

ISIN SE0015949201 / Valor 111355378

NASDAQ Nordic Exchange Stockholm, Equities (2025-04-08)
SEK 326.60+2.06%

Lifco Ab
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Lifco Ab is a company that provides a secure environment for small and medium-sized businesses. The company's main business concept is to acquire and enhance market-leading niche businesses that have the potential for sustainable earnings growth and strong cash flows. Lifco operates with a long-term perspective on its holdings, prioritizing profitability and maintaining a decentralized organizational structure. The company has three main business areas: Dental, Demolition & Tools, and Systems Solutions, with a presence in 31 countries through its 233 operating companies. In 2023, Lifco reported an EBITA margin of 23.2% on net sales of SEK 24.4 billion.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (18.12.2024):

Net Sales Growth

In the first nine months of 2024, Lifco Ab reported a 5.5% increase in net sales, reaching SEK 19,013 million compared to SEK 18,015 million in the same period of the previous year. This growth was primarily driven by acquisitions, although organic net sales saw a decline of 2.0% due to a weak market situation in certain segments.

EBITA Performance

Lifco Ab's EBITA for the January to September 2024 period increased by 2.7% to SEK 4,284 million from SEK 4,172 million in the previous year. Despite this increase, the EBITA margin experienced a slight decline to 22.5% from 23.2%, influenced by weaker earnings in specific business areas.

Profit and Earnings

For the first nine months of 2024, Lifco Ab's profit before tax decreased by 1.9% to SEK 3,194 million, while net profit for the period also declined by 1.9% to SEK 2,372 million. Earnings per share fell by 1.7% to SEK 5.14, primarily due to increased interest expenses.

Third Quarter Highlights

In the third quarter of 2024, Lifco Ab achieved a 7.4% increase in net sales, amounting to SEK 6,282 million. This growth was supported by acquisitions and a 1.9% organic sales increase. However, the EBITA margin for the quarter decreased to 22.3% from 23.2% in the previous year.

Cash Flow and Financial Position

During the January to September 2024 period, Lifco Ab's cash flow from operating activities decreased by 0.9% to SEK 2,931 million. The company maintained a strong financial position, with interest-bearing net debt amounting to 1.2 times EBITDA, providing significant scope for future acquisitions.

Summarized from source with an LLMView Source

Key figures

15.8%1Y
41.2%3Y
331%5Y

Performance

26.4%1Y
29.2%3Y
31.7%5Y

Volatility

Market cap

12303 M

Market cap (USD)

Daily traded volume (Shares)

314,196

Daily traded volume (Shares)

1 day high/low

323.6 / 319.8

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Legend Biotech Corporation
Legend Biotech Corporation Legend Biotech Corporation Valor: 54834759
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.72%USD 30.77
Concentra Group Holdings Parent Inc
Concentra Group Holdings Parent Inc Concentra Group Holdings Parent Inc Valor: 136105334
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.93%USD 19.83
aap Implantate AG
aap Implantate AG aap Implantate AG Valor: 57872565
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.23%EUR 1.65
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc DENTSPLY SIRONA Inc Valor: 31773200
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.38%USD 12.66
Acadia Healthcare Co Inc
Acadia Healthcare Co Inc Acadia Healthcare Co Inc Valor: 14151414
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.65%USD 27.12
Galapagos NV
Galapagos NV Galapagos NV Valor: 3542077
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.08%USD 23.52
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co Bristol-Myers Squibb Co Valor: 914188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.84%USD 53.07
Encompass Health Corporation
Encompass Health Corporation Encompass Health Corporation Valor: 39085960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.24%USD 97.91
International Flavors & Fragrances Inc
International Flavors & Fragrances Inc International Flavors & Fragrances Inc Valor: 941876
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.46%USD 66.85
ACELYRIN INC
ACELYRIN INC ACELYRIN INC Valor: 126441937
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-9.96%USD 2.08